Defective Cytotoxic Lymphocyte Degranulation in Syntaxin-11-Deficient Familial Hemophagocytic Lymphohistiocytosis 4 (fhl4) Patients

Yenan T. Bryceson,Eva Rudd,Chengyun Zheng,Josefine Edner,Daoxin Ma,Stephanie M. Wood,Anne Grete Bechensteen,Jaap J. Boelens,Tiraje Celkan,Roula A. Farah,Kjell Hultenby,Jacek Winiarski,Paul A. Roche,Magnus Nordenskjold,Jan-Inge Henter,Eric O. Long,Hans-Gustaf Ljunggren
DOI: https://doi.org/10.1182/blood-2007-02-074468
IF: 20.3
2007-01-01
Blood
Abstract:Familial hemophagocytic lymphohistiocytosis (FHL) is typically an early onset, fatal disease characterized by a sepsislike illness with cytopenia, hepatosplenomegaly, and deficient lymphocyte cytotoxicity. Disease-causing mutations have been identified in genes encoding perforin (PRF1/FHL2), Munc13-4 (UNC13D/FHL3), and syntaxin-11 (STX11/FHL4). In contrast to mutations leading to loss of perforin and Munc13-4 function, it is unclear how syntaxin-11 loss-of-function mutations contribute to disease. We show here that freshly isolated, resting natural killer (NK) cells and CD8(+) T cells express syntaxin-11. In infants, NK cells are the predominant perforin-containing cell type. NK cells from FHL4 patients fail to degranulate when encountering susceptible target cells. Unexpectedly, IL-2 stimulation partially restores degranulation and cytotoxicity by NK cells, which could explain the less severe disease progression observed in FHL4 patients, compared with FHL2 and FHL3 patients. Since the effector T-cell compartment is still immature in infants, our data suggest that the observed defect in NK-cell degranulation may contribute to the pathophysiology of FHL, that evaluation of NK-cell degranulation in suspected FHL patients may facilitate diagnosis, and that these new insights may offer novel therapeutic possibilities.
What problem does this paper attempt to address?